Pathogenesis of calcineurin inhibitor–induced hypertension
- 20 April 2012
- journal article
- review article
- Published by SAGE Publications in Journal Of Nephrology
- Vol. 25 (3) , 269-275
Abstract
This article reviews the current understanding of the mechanisms of calcineurin inhibitor-induced hypertension. Already early after the introduction of cyclosporine in the 1980s, vasoconstriction, sympathetic excitation and sodium retention by the kidney had been shown to play a role in this form of hypertension. The vasoconstrictive effects of calcineurin inhibitors are related to interference with the balance of vasoactive substances, including endothelin and nitric oxide. Until recently, the renal site of the sodium-retaining effect of calcineurin inhibitors was unknown. We and others have shown that calcineurin inhibitors increase the activity of the thiazide-sensitive sodium chloride cotransporter through an effect on the kinases WNK and SPAK. Here, we review the pertinent literature on the hypertensinogenic effects of calcineurin inhibitors, including neural, vascular and renal effects, and we propose an integrated model of calcineurin inhibitor-induced hypertension.Keywords
This publication has 65 references indexed in Scilit:
- Hypertension after kidney transplantationJournal Of Hypertension, 2012
- The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertensionNature Medicine, 2011
- A SPAK Isoform Switch Modulates Renal Salt Transport and Blood PressureCell Metabolism, 2011
- Renal Nerves, WNK4, Glucocorticoids, and Salt TransportCell Metabolism, 2011
- Cyclosporine metabolic side effects: association with the WNK4 systemEuropean Journal of Clinical Investigation, 2011
- HNF4alpha Dysfunction as a Molecular Rational for Cyclosporine Induced HypertensionPLOS ONE, 2011
- SPAK-Knockout Mice Manifest Gitelman Syndrome and Impaired VasoconstrictionJournal of the American Society of Nephrology, 2010
- Sympathoexcitation in calcineurin inhibitor-induced hypertension: villain or innocent bystander?Journal Of Hypertension, 2010
- Cyclosporine stimulates the renal epithelial sodium channel by elevating cholesterolAmerican Journal of Physiology-Renal Physiology, 2009
- Endothelial dysfunction in renal transplant recipients maintained on cyclosporineKidney International, 2000